Centers for Disease Control and Prevention Economic Studies of Immunization Policies and Practices | RFA IP 15 00103CONT17

Opportunity Information: Apply for RFA IP 15 00103CONT17

The Centers for Disease Control and Prevention Economic Studies of Immunization Policies and Practices opportunity is a CDC funding announcement focused on generating and applying economic evidence to support immunization decision-making. In practical terms, the program is designed to strengthen the economic foundations behind vaccine policies and program operations by supporting studies that examine the costs, benefits, and broader value of immunization strategies, as well as the economic implications of how vaccines are delivered in real-world settings. The emphasis is on work that can inform policy and practice, such as evaluating alternative vaccination schedules or recommendations, assessing strategies to improve vaccination uptake, estimating the cost-effectiveness of specific immunization interventions, and analyzing program and provider-level costs that influence implementation and sustainability.

This particular listing is identified as a continuation opportunity rather than a brand-new competition, which typically indicates that it is intended to continue or extend work under an existing project framework or a previously awarded effort. The funding mechanism is a cooperative agreement, meaning recipients generally do not operate in isolation the way they might under a standard grant. Instead, a cooperative agreement usually involves substantial federal involvement, with CDC scientific or program staff collaborating with awardees in ways such as refining study questions, aligning methods with CDC information needs, coordinating data approaches, and helping translate findings into policy-relevant outputs. The activity category is health, and the associated CFDA number is 93.083, which is commonly tied to CDC immunization-related assistance.

The opportunity is administered by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), using the CDC electronic research administration (ERA) platform. The funding opportunity title is Centers for Disease Control and Prevention Economic Studies of Immunization Policies and Practices, and the funding opportunity number is RFA IP 15 00103CONT17. The posting shows a creation date of January 13, 2017, with an original closing date of March 22, 2017, indicating the window when applications or continuation materials were due for that cycle.

In terms of who may apply, the eligibility field points to "Others" with additional eligibility details referenced in the full announcement. In federal listings, this often means eligibility can include a range of non-traditional categories depending on the program, such as academic institutions, non-profits, research organizations, and other entities with demonstrated capacity to perform applied economic and policy research in immunization. Because eligibility is not fully specified in the excerpt, applicants would normally need to consult the announcement's eligibility section to confirm whether their organization type is allowed and whether there are any special conditions tied to being a continuation.

The award information included in the source data indicates an expected number of awards of 10, suggesting CDC anticipated supporting multiple projects or sites under this continuation. The award ceiling is listed as 0, which is commonly used in listings when a specific maximum award amount is not provided in the summary record or may vary by recipient, scope, or available funds. In those cases, the full funding announcement or continuation guidance typically provides the actual budget parameters, including allowable cost categories, indirect cost treatment, and any constraints tied to study design, data acquisition, or dissemination.

Overall, the opportunity is best understood as CDC support for rigorous economic analyses that help answer policy-relevant questions about immunization: what different vaccination policies cost, what outcomes they produce, how cost-effective they are, what implementation choices mean for budgets and efficiency, and how programs can allocate resources in ways that improve health impact. Because it is structured as a cooperative agreement and described as a continuation, it also implies ongoing coordination with CDC priorities and an expectation that results will be timely, methodologically sound, and directly usable for immunization program planning, evaluation, and policy development.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Economic Studies of Immunization Policies and Practices" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.083.
• This funding opportunity was created on Jan 13, 2017.
• Applicants must submit their applications by Mar 22, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA IP 15 00103CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: